MedTrace Logo

The Effect of Caffeine Ingestion in Prevention of Postoperative Ileus After Caesarean Section.

NCT03815877 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2019-01-24

No results posted yet for this study

Summary

Many trials have been made to prevent paralytic ileus , including administration of prokinetic drugs , early resumption of feeding, gum chewing and adequate pain control. Unfortunately, none of these strategies has been completely successful. Recently the effect of caffeine on prevention of postoperative ileus after caesarian section was researched. That's why this study is designed to determine the efficacy of caffeine in prevention of postoperative ileus after caesarean section.

Conditions

  • Postoperative Ileus
  • Cesarean Section Complications
  • Caffeine

Interventions

DIETARY_SUPPLEMENT

Nescafe Gold ® coffee

Nescafe Gold ® coffee (5gm per 100cc water containing 170 mg of caffeine) will be used for all the women in the intervention group. \- patients will drink 100cc coffee with 1 tea spoon added sugar at 3, 6 and 9 hours after the surgery.

DIETARY_SUPPLEMENT

Nescafe Gold DECAF® coffee

Nescafe Gold DECAF coffee (5 gm per 100cc water containing 5-10 mg of caffeine) will be used for all the women in the control group. the control group will drink 100cc decaffeinated coffee with 1 tea spoon added sugar at 3, 6 and 9 hours after the surgery.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • AMR NADIM · Ain Shams University

  • REDA GHANEM · Ain Shams University

  • MADONNA BENYAMINE · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-17
Primary Completion
2018-12-10
Completion
2019-01-12

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03815877 on ClinicalTrials.gov